Evidence map›Paper›PMID 41623732›Full record

ArticleJournal of pathology informatics2026

An integrated system from microscopy to AI for real-time object detection in endometrial cytology.

Mika Terasaki, Shun Tanaka, Ichito Shimokawa, Etsuko Toda, Shoichiro Takakuma, Yusuke Kajimoto, Shinobu Kunugi, Akira Shimizu, Yasuhiro Terasaki

Abstract read
In one paragraph

Article in Journal of pathology informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mika TerasakiDepartment of Analytic Human Pathology, Nippon Medical School, 1-25-16, Nezu, Bunkyo-ku, Tokyo 113-0031, Japan.
Shun TanakaDepartment of Analytic Human Pathology, Nippon Medical School, 1-25-16, Nezu, Bunkyo-ku, Tokyo 113-0031, Japan.
Ichito ShimokawaDepartment of Analytic Human Pathology, Nippon Medical School, 1-25-16, Nezu, Bunkyo-ku, Tokyo 113-0031, Japan.
Etsuko TodaDepartment of Analytic Human Pathology, Nippon Medical School, 1-25-16, Nezu, Bunkyo-ku, Tokyo 113-0031, Japan.
Shoichiro TakakumaDepartment of Analytic Human Pathology, Nippon Medical School, 1-25-16, Nezu, Bunkyo-ku, Tokyo 113-0031, Japan.
Yusuke KajimotoDivision of Pathology, Nippon Medical School Musashi Kosugi Hospital, 1-383, Kosugimachi, Nakahara-ku, Kawasaki 211-8533, Kanagawa, Japan.
Shinobu KunugiDepartment of Analytic Human Pathology, Nippon Medical School, 1-25-16, Nezu, Bunkyo-ku, Tokyo 113-0031, Japan.
Akira ShimizuDepartment of Analytic Human Pathology, Nippon Medical School, 1-25-16, Nezu, Bunkyo-ku, Tokyo 113-0031, Japan.
Yasuhiro TerasakiDepartment of Analytic Human Pathology, Nippon Medical School, 1-25-16, Nezu, Bunkyo-ku, Tokyo 113-0031, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial cytology, which is minimally invasive and available as an outpatient procedure, is widely used in Japan for early detection of endometrial cancer, but its diagnostic process is time-consuming and requires expert diagnosticians. We developed a real-time artificial intelligence (AI)-assisted system using a standard microscope, a charge-coupled device (CCD) camera, and the You-Only-Look-Once version 5x (YOLOv5x) (a well-established object detection model) to support endometrial cytology screening in resource-limited settings. A total of 146 pre-operative cytology cases were collected, and the model was trained to detect abnormal cell clusters. The system was evaluated in real-time using a CCD camera, and its diagnostic performance was compared with that of three pathologists and four medical students. In an independent test of 20 cases, the AI model achieved an accuracy of 85%, showing promising performance comparable to the average accuracy of 75% among human evaluators. Furthermore, the median diagnostic time was reduced by approximately 45% with AI assistance. The impact of AI support varied by user expertise, with notable improvements among non-specialists. This proof-of-concept study demonstrates the feasibility and potential of affordable, real-time AI support for endometrial cytology using widely available equipment. Further validation with larger, multicenter datasets is warranted to confirm the generalizability and clinical utility of this approach.

Indexed as

Artificial intelligenceDigital pathologyEndometrial cytologyObject detectionPathology workflow integrationReal-time supportYOLOv5x

Identifiers

PMID41623732
PMCPMC12859783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.